William J Penn, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 201 Tahoma Blvd, Suite 102, Yelm, WA 98597 Phone: 360-458-7761 |
News Archive
New preclinical data on velafermin (CG53135), CuraGen's Phase II clinical product being developed for the prevention of oral mucositis (OM), suggesting that velafermin may protect the gastrointestinal tract and decrease associated toxicity, including enteritis and diarrhea, following exposure to radiation.
About 11 million people - roughly 1-in-25 Americans - are now believed to be affected by one or more food allergies, a disease triggered by the ingestion or contact with certain foods that may cause life-threatening reactions, or anaphylaxis, according to a recent Food Allergy & Anaphylaxis Network nationwide survey.
Outpatient care for certain low-risk patients with pulmonary embolism (PE) can be safely and effectively used in place of inpatient care, according to a randomized, multi-center study in 19 emergency departments.
Scientists working at the Institute for Cancer Research have found a new anti-cancer target in MAP4K3, an enzyme which is able to 'switch on' the growth-promoter mTOR.
› Verified 6 days ago